Browsing Tag
Merck
96 posts
Merck acquires ArQule for $2.7bn to further diversify oncology pipeline
Merck acquisition of ArQule : Merck has completed its previously announced acquisition of ArQule for $20 per share…
January 18, 2020
Merck acquires Calporta Therapeutics from COI Pharmaceuticals
Merck acquisition of Calporta : Merck has acquired Calporta Therapeutics from COI Pharmaceuticals in a deal worth up…
November 15, 2019
Chinese biopharma company Akeso raises $150m for antibody drug discovery
Akeso, a Chinese biopharma company engaged in antibody drug discovery and development in oncology and immunology therapeutic areas,…
November 11, 2019
Merck bags Recarbrio FDA approval for urinary tract and intra-abdominal infections
Recarbrio FDA approval : Merck & Co. has secured approval from the US Food and Drug Administration (FDA)…
July 17, 2019
Merck to acquire US biopharma company Peloton Therapeutics in $2.2bn deal
Merck acquisition of Peloton : Pharma giant Merck is set to acquire US biopharma company Peloton Therapeutics in…
July 14, 2019
Pharma giants bag Lynparza EMA approval for metastatic breast cancer
Lynparza EMA approval : Pharma giants AstraZeneca and MSD have secured an expansion of the European Medical Agency’s…
May 19, 2019
EMD Serono facility expansion in Massachusetts set to advance immuno-oncology research
German pharmaceutical giant Merck KGaA has announced a significant investment of $70 million to expand its EMD Serono…
February 16, 2019
Merck to invest $70m in expansion of US biopharma facility
German pharmaceutical giant Merck is set to invest $70 million to expand its EMD Serono research and development…
February 16, 2019
Procter & Gamble completes game-changing acquisition of Merck’s consumer health unit
In a significant boost to its consumer health portfolio, Procter & Gamble (P&G) has concluded its €3.4 billion…
December 1, 2018
Merck secures EC approval for Keytruda in combination therapy for lung cancer
Merck has achieved a significant milestone by obtaining approval from the European Commission (EC) for its cancer immunotherapy,…
September 12, 2018